Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
Titel:
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
Auteur:
Earl, Helena M Vallier, Anne-Laure Hiller, Louise Fenwick, Nicola Young, Jennie Iddawela, Mahesh Abraham, Jean Hughes-Davies, Luke Gounaris, Ioannis McAdam, Karen Houston, Stephen Hickish, Tamas Skene, Anthony Chan, Stephen Dean, Susan Ritchie, Diana Laing, Robert Harries, Mark Gallagher, Christopher Wishart, Gordon Dunn, Janet Provenzano, Elena Caldas, Carlos
Verschenen in:
Lancet oncology
Paginering:
Jaargang 15 (2014) nr. 2 pagina's 12 p.
Jaar:
2014
Inhoud:
Uitgever:
Earl et al. Open Access article distributed under the terms of CC BY-NC-ND